| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. | J Am Acad Dermatol | 2012 | 2.00 |
| 2 | Advanced age exacerbates the pulmonary inflammatory response after lipopolysaccharide exposure. | Crit Care Med | 2007 | 1.22 |